Journal List > Korean J Clin Neurophysiol > v.18(1) > 1084171

Ahn, Song, Kim, Jang, Sohn, and Choi: Relation of Bony Carotid Canal Diameter and Clinical Manifestations in Patients with Moyamoya Disease

Abstract

Background:

Moyamoya disease is characterized by a progressive stenosis or occlusion of the intracranial internal carotid artery and/or the proximal portion of the anterior cerebral artery and middle cerebral artery. Whether the onset time was childhood or adulthood, the bony carotid canal diameter might be different, but reflects the size of internal carotid artery passing through the bony carotid canal. In this study, we aimed to identify the relationship between bony carotid canal diameter and clinical manifestation.

Methods:

146 consecutive patients diagnosed with moyamoya disease by brain imaging studies were included. We measured the diameter of a transverse portion of bony carotid canal on bone window of a brain computed tomography(CT) image. Patients were divided into two groups, ischemic or hemorrhagic stroke according to clinical manifestation. As a result, 115 patients were included. The Suzuki stage was used as criteria for disease progression.

Results:

Bony carotid canal diameter was 3.6 ± 0.5 (right) and 3.6 ± 0.4 (left) in the hemorrhagic stroke group, and 3.7 ± 0.4 (right) and 3.6 ± 0.4 (left) in the ischemic stroke group. The bony carotid canal diameter of the moyamoya vessels (3.6 mm) was smaller than the diameter of non-moyamoya vessels (3.8 mm), significantly (p = 0.042). However, there was no difference in the collateral patterns and clinical manifestation in a comparison of both groups.

Conclusions:

In our study, there was no significant difference of clinical manifestations and collateral patterns depend on the bony carotid canal diameter in patients with moyamoya disease. These findings suggest that the clinical presentations of moyamoya disease are not related to the onset time of the disease. (Korean J Clin Neurophysiol 2016;18:1-6)

REFERENCES

1.Guey S., Tournier-Lasserve E., Herve D., Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015. 8:49–68.
2.Hertza J., Loughan A., Perna R., Davis AS., Segraves K., Tiberi NL. Moyamoya disease: a review of the literature. Appl Neuropsychol Adult. 2014. 21:21–27.
crossref
3.Baba T., Houkin K., Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008. 79:900–904.
crossref
4.Han DH., Kwon OK., Byun BJ., Choi BY., Choi CW., Choi JU, et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien). 2000. 142:1263–1273.
5.Wakai K., Tamakoshi A., Ikezaki K., Fukui M., Kawamura T., Aoki R, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997. 99(Suppl 2):S1-S5.
crossref
6.Motoshima S., Noguchi T., Kawashima M., Ooishi M., Irie H., Nishihara M, et al. Narrowed petrous carotid canal detection for the early diagnosis of moyamoya disease. Fukuoka Igaku Zasshi. 2012. 103:206–214.
7.Watanabe A., Omata T., Koizumi H., Nakano S., Takeuchi N., Kinouchi H. Bony carotid canal hypoplasia in patients with moyamoya disease. J Neurosurg Pediatr. 2010. 5:591–594.
crossref
8.Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997. 99(Suppl 2):S238-S240.
9.Hashimoto N., Tominaga T., Miyamoto S., Nagata I., Houkin K., Suzuki N, et al. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012. 52:245–266.
10.Suzuki J., Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969. 20:288–299.
11.Liu W., Xu G., Liu X. Neuroimaging diagnosis and the collateral circulation in moyamoya disease. Interv Neurol. 2013. 1:77–86.
crossref
12.Cali RL., Berg R., Rama K. Bilateral internal carotid artery agenesis: a case study and review of the literature. Surgery. 1993. 113:227–233.
13.Handa J., Matsuda I., Nakasu S., Nakano Y. Agenesis of an internal carotid artery: angiographic, tomographic and computed tomographic correlation. Neuroradiology. 1980. 19:207–211.
crossref
14.Quint DJ., Silbergleit R., Young WC. Absence of the carotid canals at skull base CT. Radiology. 1992. 182:477–481.
crossref
15.Fujimura M., Mugikura S., Shimizu H., Tominaga T. Asymptomatic moyamoya disease subsequently manifesting as transient ischemic attack, intracerebral hemorrhage, and subarachnoid hemorrhage in a short period: case report. Neurol Med Chir (Tokyo). 2010. 50:316–319.
16.He Y., Zhou Q., He M. An asymptomatic Moyamoya disease: autopsy case and literature review. Am J Forensic Med Pathol. 2010. 31:77–79.
17.Ikeda K., Iwasaki Y., Kashihara H., Hosozawa K., Anan K., Tamura M, et al. Adult moyamoya disease in the asymptomatic Japanese population. J Clin Neurosci. 2006. 13:334–338.
crossref
18.Jo KI., Yeon JY., Hong SC., Kim JS. Clinical course of asymptomatic adult moyamoya disease. Cerebrovasc Dis. 2014. 37:94–101.
crossref
19.Kuroda S., Ishikawa T., Houkin K., Nanba R., Hokari M., Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke. 2005. 36:2148–2153.
crossref

Figure 1.
Measurement of bony carotid canal diameter. Bony carotid canal diameter was measured by transverse portion of bony carotid canal on bone window setting of brain CT (diameter of bidirectional arrow). CT; computed tomography.
kjcn-18-1f1.tif
Figure 2.
Relations of Suzuki stages and bony carotid canal diameter. Bony carotid canal diameter was compared in each ischemic and hemorrhage group according to Suzuki criteria.
kjcn-18-1f2.tif
Figure 3.
Relations of bony carotid canal size and collateral patterns. Bony carotid canal size was divided into two groups. Average of moyamoya disease vessel diameter (3.6 mm) was the standard of small and large groups. Each group showed different collateral patterns. BCC; bony carotid canal.
kjcn-18-1f3.tif
Figure 4.
Relations of clinical manifestation and collateral patterns. Clinical manifestation was divided into two groups, ischemic and hemorrhagic stroke group. Each group showed different collateral patterns.
kjcn-18-1f4.tif
Table 1.
Classification of collateral pattern of moyamoya vessel
Collateral pattern of moyamoya vessel
1 Anterior cerebral artery → meningeal arteries → Middle cerebral artery
2 Dilation and extension of the anterior choroidal artery beyond the choroid fissure
3 Patent posterior communicating artery → posterior cerebral artery → meningeal arteries → Anterior cerebral artery and/or Middle cerebral artery
4 posterior choroidal artery → the posterior pericallosal artery → Anterior cerebral artery
5 Posterior cerebral artery → meningeal arteries → Anterior cerebral artery and/or Middle cerebral artery
6 Ophthalmic artery → neovessels → Anterior cerebral artery
7 Middle meningeal arteries → Anterior cerebral artery and/or Middle cerebral artery
8 Superficial temporal artery → Middle cerebral artery
9 Occipital artery → Anterior cerebral artery and/or Middle cerebral artery
Table 2.
Baseline characteristics of moyamoya disease patients
Hemorrhage (n = 57) Ischemia (n = 58) p
Age, years 53.3 ± 12.0 46.9 ± 18.2 0.029
Female 36 (63.2) 40 (69.0) 0.511
Type 0.646
Unilateral 21 (36.8) 19 (32.8)
Bilateral 36 (63.2) 39 (67.2)
Suzuki criteria 0.694
I-II 12 (20.7) 11 (19.3)
III 26 (44.8) 22 (38.6)
IV-V 20 (34.5) 24 (42.1)
Bony carotid ca anal diameter
Right, mm 3.6 ± 0.5 3.7 ± 0.4 0.502
Left, mm 3.6 ± 0.4 3.6 ± 0.4 0.838

Values are presented as mean ± SD or n (%).

TOOLS
Similar articles